The Principal Investigator. 5.1. Xx. Xxxxxx Xxxxxx, MD of the Medical Center (hereinafter: “the Pricipal Investigator”) has agreed to serve as the principal investigator of the Trial
The Principal Investigator for the Contract or Grant shall be responsible for executing the project in conformance with the approved budget.
The Principal Investigator i. CV Higher education • MA in Germanic Philology, Department of Germanic Studies, Faculty of Arts, University of Bologna (Italy). Masters thesis ‘The diffusion of the Visio Tnugdali in Germanic literatures of the Middle Ages’ (cum laude, 19 November 1993). • PhD in Middle Dutch Literature, Department of Dutch Literature, Faculty of Arts, University of Leiden (the Netherlands). Supervisor: Prof. xx Xxxxx xxx Oostrom. Thesis defended on 17 May 2000. Title: Italiaanse deugden en ondeugden. Dirc Potters Xxxxx der doechden en de Italiaanse Xxxxx di Virtù (Italian Virtues and Vices. Xxxx Xxxxxx’x Xxxxx der doechden and the Italian Xxxxx di Virtù). This doctoral thesis offers a comparative study of the Middle Dutch text Xxxxx der doechden, by the Middle Dutch writer Xxxx Xxxxxx (1370–1428), and the Italian didactic treatise Xxxxx di virtù, written in Bologna in the first decades of the 14th century. The study attempts to define the relationship between the Middle Dutch and the Italian. The textual and philological analysis is completed by a detailed study of the life of Xxxx Xxxxxx, who resided in Rome between 1411 and 1412, the first Middle Dutch writer to undertake such a journey. Work experience and research positions • Research Institute for Medieval Studies, University of Leiden (the Netherlands). Coordinator of research and teaching activities, 1 April 1999 to 1 September 1999.
The Principal Investigator the SPONSOR and the monitors and auditors will observe the internal procedural rules of the HOSPITAL and the FOUNDATION, which will be provided by the latter, and also the indications on the performance of the CLINICAL TRIAL given by the CEIm responsible for monitoring them.
The Principal Investigator. 1. The “principal investigator” as defined in Annex II is (Name, date and place of birth of the principal investigator) [‘nationality, passport No xxxx, Id number…].
The Principal Investigator. For sake of clarity, the Principal Investigator is an employee of Institution and will be named in Exhibit A. The Principal Investigator represents and certifies that he or she has read and understands the Investigator’s protocol and brochure. The Principal Investigator is not a party but must read, sign and acknowledge the entire agreement. During the Study, the Institution shall immediately notify SPONSOR in writing at such time as it becomes aware that the Principal Investigator plans to leave the Institution or shall be unable to complete the Study. If the Institution and SPONSOR are unable to agree on an acceptable substitute investigator within fifteen (15) business days following such notice, SPONSOR may terminate this Agreement pursuant to Section 24.
The Principal Investigator. Xxxxxx Xxx Xxxx – will coordinate the entire project and will have full responsibility of the project development.
The Principal Investigator. For sake of clarity, the Principal Investigator is an employee of Institution and will be named in Exhibit A. The Principal Investigator represents and certifies that he or she has read and understands the Investigator’s Brochure. The Principal Investigator is not a party but must sign off read and acknowledged to the entire agreement. Prior to the commencement of the Study, the Principal Investigator shall deliver to AstraZeneca true, complete and correct copies of the Principal Investigator’s investigator statement on U.S. Food and Drug Administration (“FDA”) Form 1572 and curriculum vitae, each of which shall be signed by the Principal Investigator. During the Study, the Institution shall immediately notify AstraZeneca in writing at such time as it becomes aware that the Principal Investigator plans to leave the Institution or shall be unable to complete the Study. If the Institution and AstraZeneca are unable to agree on an acceptable substitute investigator within fifteen (15) business days following such notice, AstraZeneca may terminate this Agreement pursuant to Section 24.
The Principal Investigator. 5.1. Xx. Xxxxxxxx Xxxxxx MD, of HMO (hereinafter: “the Principal Investigator”) has agreed to serve as the principal investigator of the Trial.
The Principal Investigator and the Institution must use the wording below when acknowledging a grant from XXXXX. When appropriate, such as in a scientific journal article, the grant number must be included. ‘Funding for xxx - grant number was obtained from XXXXX UK.’
